1. Field of the Invention
In follow-up oncology examinations the main medical question under scrutiny often is whether the patient's overall condition has been improved or has declined. This allows conclusions to be drawn on the effectiveness of treatment options and often influences the treatment planning. The present invention seeks to provide methods and apparatus to enable a user to compare results of two or more medical image scans, e.g. CT, MR, PET, or SPECT scans, acquired at different time-points. Such methods and apparatus may save time for the user, and supports the interpretation of the images.
2. Description of the Prior Art
In oncological follow-up examinations, a treating physician is required to quickly assess how the disease has developed since the previous scan. In the case of multiple lesions and/or metastases, collecting and interpreting the required information can be time-consuming. Moreover, in certain cases the development of lesions can differ in different regions. For example, after chemotherapy the primary tumor might show positive development, for example indicated by a reduction in PET tracer uptake, while a secondary tumor may have evolved, for example indicated by an increase in PET tracer uptake. Finally, the collected information might need to be effectively presented to a person without medical education.
In clinical practice, multiple time-points are either qualitatively or quantitatively compared using 2D and 3D representations of the acquired medical data (e.g. MPR slices or MIP renderings). In the use case of combined PET/CT examinations, a user may conventionally qualitatively compare lesions by visually comparing the uptake of the injected radiopharmaceutical in different VOIs. Particularly MIP representations of the acquired PET scan are helpful to get a good overview of the patient's condition. For quantitative comparisons, typically each lesion needs to be delineated and the resulting quantitative measurements of correlating lesions need to be compared. Finally, the user needs to mentally combine all available information, qualitative and quantitative, to draw a conclusion, for example for deciding on future treatment. This task may be further complicated if changes in measurements of response from different body regions are inconsistent over the timepoints considered.
A conventional approach to assessing potentially heterogeneous response is proposed by a system known as PERCIST. In PERCIST, a single representative lesion is selected per timepoint: specifically the lesion with the highest peak SUV. However, this approach is unable to take into account any inter-lesion or regional differences in response. Such differences may affect therapy selection, such as a choice of targets for targeted radiotherapy.
The present invention accordingly provides an improved method and system for efficient assessment of lesion development.
The present invention describes a system and method to efficiently assess and visually represent a change in medical image data representing lesions. In preferred embodiments, a level of detail of the visualized comparison can be varied, such as from an individual lesion level to a view representing the overall condition of the patient. In certain embodiments, the invention provides a multi-level summary view representing the progress of tracer uptake in a patient, which may be used in the assessment of a progressive disease.
The present invention provides a method for visually representing quantitative changes in image data such that a user can easily evaluate the qualitative and quantitative development of a represented feature such as a lesion.
The following definitions, acronyms, and abbreviations are used herein:
CT Computed tomography
MRI Magnetic resonance imaging
PET Positron emission tomography
SPECT Single-photon emission tomography
MIP Maximum intensity projection
MPR Multi-planar reformatting/reconstruction/rendering
VOI Volume of Interest
TP Time-point
CAD Computer-assisted diagnosis
NM Nuclear medicine
PERCIST PET Response Criteria in Solid Tumors
SUV Standardized Uptake Value.
Each of
In an example embodiment, the invention includes the following steps:
1. Extraction of quantitative measurements of correlated lesions from different time-points
2. Visual representation of change of one or more extracted measurements
3. Combination of multiple change measures into one visual representation based on anatomical information, e.g., organ segmentations
4. Opportunities for the user to interact with the system.
The present invention also provides a system for performing such methods. The system may be implemented in a computer.
The above steps and methods are detailed in the following subsections.
1. Extraction of Quantitative Measurements
In the first step of the example method given above, the user identifies one or more lesions in medical images from two or more time-points. These lesions can be manually identified, suggested by the system, or fully automatically identified by a CAD algorithm. Furthermore, representations of lesions can be identified on each medical image individually and linked between time-points by user action or automatically propagated from one timepoint to the other(s).
For each lesion, quantitative measurements are extracted such as lesion volume, mean/max intensity information, among others. Note that each time-point may combine information from multiple modalities, multiple scan protocols and reconstructions or in the case of NM from multiple tracers.
In the remainder of this document all examples will be simplified to the use-case of PET/CT examinations from two time-points with focus on quantitative PET measurements, as a non-limiting example sufficient to explain the invention when applied to any modality.
Not only lesions as a whole, but also sub-lesion measures can be extracted, evaluated and displayed according to the present invention. For example, CT-based necrosis analysis to extract the non-necrotic lesion fraction and only that fraction evaluated and displayed. Change in such quantitative measures can be evaluated and visualized according to the present invention.
2. Visual Representation of Change
Given a finding from two time-points, a qualitative notion of change can be extracted from quantitative measurements: whether the lesion has improved, such as may be expected following treatment; or has progressed. In PET imaging, a decreased maximum SUV measure could be used as indication of improvement while in CT imaging a reduced tumor size might be utilized for the same purpose. In general, a change in one measurement or a combination of multiple measurements, possibly extracted from different modalities, can be translated into the aforementioned notion of change.
This change is then visualized in combination with the tumor delineation. Example realizations to represent the change include, but are not limited to, color-coded contouring of the tumor, color-coded overlays, and color-coded silhouette visualizations in conjunction with volume rendering techniques, such as MIPs. An example is shown in
In a preferred realization, the visual representation of change is combined with volume rendering techniques, such that a user can evaluate all lesions in one glance and mentally combine the visual impression of the lesions from the simplified/reduced quantitative information extracted by comparing quantitative measurements.
Extracted change information can be combined into region-based visual representations using anatomical information. For instance, anatomical information may be augmented and used to classify each lesion according to its host organ and all change metrics within an organ of interest can be combined into one visual representation of change using a combination of measurements extracted from multiple lesions within the organ. Such combination may be weighted, for example to give extra weight to tracer count from a certain selected lesion. For the example of PET/CT studies, such anatomical information can be derived using CT-based organ segmentations (Kohlberger, et al. “Automatic Multi-Organ Segmentation Using Learning-based Segmentation and Level Set Optimization”, MICCAI 2012, Springer LNCS and US Patent Application 2012/0230572), or bone segmentations, PET-based organ segmentations or other body-region detection algorithms including the delineation of the whole body outline. Thus-defined change can then be visualized, but instead may be visualized on an organ, bone, body-region, or whole-body level, at the choice of the user such as illustrated in the example drawings of
3. Combination of Multiple Change Measures
A multitude of lesions can be combined into functional groups by either anatomical information or based on user interaction. As a consequence, the level of detail presented to the user is decreased.
Not only anatomical information such as organ delineations may be used to group different lesions but also any other arbitrary region may be employed, for example as defined on a reference volume serving as atlas. Alternatively, a user may arbitrarily assign selected lesions to a group, and development of the lesions within that group will be visualized and represented for a user to interpret.
A non-rigid registration can be used to identify lesions belonging to a particular group. In a similar manner, lesions may be grouped based on a corresponding host or neighboring tissue type, such as air (in lungs); fat; bone, etc. This information can be extracted using conventional image processing techniques. For instance in MR/PET, the Dixon scan protocol (MR) is commonly employed to segment the patient data into different tissue classes (Hoffmann, et al. “MRI-based attenuation correction for whole-body PET/MRI: quantitative evaluation of segmentation- and atlas-based methods”, J Nucl Med, 52(9), pp. 1392-9, 2011).
4. User Interaction
The invention further includes arrangements enabling a user to interact with the system. In one embodiment, the overall patient development may be viewed as a single representation, for example by a color-coded silhouette of the body outline visualized superimposed to the PET MIP, such as shown in
Although the present invention has been described with particular reference to lesions, it may be embodied so as to present information on the change of any characteristic of a human or animal subject.
Although the present invention has been described with reference to presenting the comparisons in graphical form using color coding, other arrangements may be employed, within the scope of the present invention. Rather than color, intensity or shading patterns may be used to signal the results of the comparison. Alternatively, the results may be presented in text form, either as labels on a graphical representation, or as a purely-text output, for example listing the names of various organs and the result of the comparison. In a top-level display, where an overall state of a patient is represented, the text output may comprise a patient's name or other identifier, and a text-based indication of the outcome of the comparison.
Referring to
For example, a central processing unit 4 is able to receive data representative of medical scans via a port 5 which could be a reader for portable data storage media (e.g. CD-ROM); a direct link with apparatus such as a medical scanner (not shown) or a connection to a network.
For example, in an embodiment, the processor performs such steps as: capturing medical image data of a patient at at least two different timepoints, said data representing a property of each of the at least one region-of-interest at each of the timepoints; comparing the data representing a corresponding region-of-interest at the different timepoints; and presenting a representation to a user indicating a change in the property of at least one of the regions-of-interest, with an indication of the region-of-interest associated with the representation.
Software applications loaded on memory 6 are executed to process the image data in random access memory 7.
A Man-Machine interface 8 typically includes a keyboard/mouse/screen combination to allow user input such as initiation of applications, and a screen on which the results of executing the applications are displayed.
Although modifications and changes may be suggested by those skilled in the art, it is the intention of the inventors to embody within the patent warranted hereon all changes and modifications as reasonably and properly come within the scope of their contribution to the art.
Number | Date | Country | Kind |
---|---|---|---|
1308866.1 | May 2013 | GB | national |